INSIGHTS ON FACILITY DESIGN
-
![iStock-1153276321-lab-technology-check-quality]( "Transforming Your Biopharma Automation Capabilities")
Transforming Your Biopharma Automation CapabilitiesThe seamless functionality of single-use technology equipped with a scalable distributed control system (DCS) empowers you to capture the benefits of collecting and sharing data while simultaneously creating a connected enterprise that grows with the pace of your business.
-
![Cytiva-EnterpriseSolutions35]( "Improving The Supply Of Single-Use Technologies")
Improving The Supply Of Single-Use TechnologiesThe use of single-use technologies has been growing steadily over the past decade, but there are challenges. Explore the potential solutions for single-use supply constraints.
-
![iStock-1214627273-development-lab]( "Cleanliness Is Next To Godliness In The Manufacture Of Medicinal Products")
Cleanliness Is Next To Godliness In The Manufacture Of Medicinal ProductsCleanrooms are used extensively in the pharmaceuticals, biotech, medical device, and life sciences industries to reduce particulate contamination and to control other environmental parameters, including temperature, humidity, and pressure.
-
![Vaccines 2]( "Vaccines Development, Regulations And Manufacturing Part-2")
Vaccines Development, Regulations And Manufacturing Part-2In Part 2, we will review vaccine processes with examples based upon influenza vaccine, inactivated Polio vaccine and an overview of the different types of vaccine production processes from cell expansion, USP and DSP, to the formulation and filling operations to make the finished product. We will talk about vaccine production facilities, how equipment is integrated their operating principles and biological safety levels for containment. Finally, we will look at the vaccine industry today, the supply chain and globalization, and how important vaccines are in pandemic preparedness, availability, and time to market.
-
Improve Bioprocessing Efficiency With A Standardized Automation Platform3/9/2021
Designed specifically for the biomanufacturing industry, Cytiva's Figurate automation is a portfolio of automation platform solutions powered by the reliability of Emerson’s DeltaV.
-
High-Quality Chromatography System Meets Predesigned DeltaV For Integrated Manufacturing3/9/2021
Cytiva’s pre-defined automation solution, Figurate™️, is now available as a turnkey solution by combining our industry-leading ÄKTA™️ process chromatography system with the reliability of the DeltaV DCS platform.
-
Achieving Business Continuity In Pharma During COVID-19 Restrictions3/4/2021
To ensure business continuity during COVID-19 restrictions, we developed a virtual factory acceptance testing solution that allowed SaudiVax to advance their manufacturing plan.
-
How To Prepare For Future Viral Vector Manufacturing Technologies And Platforms3/1/2021
The challenges and shortage of vector production reflect the fact that these materials and products are having such strong clinical success. Let’s celebrate the reason for this demand. To meet it, we need to industrialize and rethink how we transition from what has historically been carried out in translational clinical centers at smaller scale, using flasks and open systems, towards commercial production and methodologies.
-
Effectively Managing Data In Process Development1/11/2021
Addressing data management challenges during drug development requires an understanding of today’s shortcomings and the factors to consider when adopting a solution to overcome them.
FACILITY DESIGN SOLUTIONS
-
![genderless-aseptiquik-l-series-connectors]( "Genderless AseptiQuik® L Series Connectors")
Genderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.
-
In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.
-
To fulfill the increasing demand of life-saving solutions for patients' lives all over the world, we decided to drive forward with building our new facility, Plant 4. Our accumulated expertise is implemented with the latest technologies and innovation, so that Plant 4 will be able to serve as part of your global presence, becoming your future biomanufacturing hub.
-
![CPC]( "Genderless AseptiQuik® L Series Connectors Datasheet")
Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error.
-
As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.
